Back
iShares Morningstar US Equity ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
58
ILCB
iShares Morningstar US Equity ETF
Last Price:
$95.55
Seasonality Move:
0.72%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$35.06
Seasonality Move:
-22.7%
Buy
58
iShares Morningstar US Equity ETF (ILCB)
is a Buy
Is iShares Morningstar US Equity ETF a Buy, Sell or Hold?
-
The current iShares Morningstar US Equity ETF [ILCB] share price is $95.49. The Score for ILCB is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ILCB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ILCB Stock Price Chart
What is iShares Morningstar US Equity ETF's stock price today?
-
The iShares Morningstar US Equity ETF share price today is $95.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ILCB is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $35.09The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
ILCB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 59.55 | Buy |
| Chaikin Money Flow: | -7305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.66 - 95.28) | Buy |
| Bollinger Bands (100): | (89.88 - 94.34) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.23 | Buy |
| Relative Strength Index (14 RSI): | 66.16 | Buy |
| Chaikin Money Flow: | -92149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.48 - 34.66) | Buy |
| Bollinger Bands (100): | (10.81 - 25.25) | Buy |
ILCB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.25 | Buy |
| 20-day SMA: | 94.49 | Buy |
| 50-day SMA: | 93.76 | Buy |
| 200-day SMA: | 86.45 | Buy |
| 8-day EMA: | 94.67 | Buy |
| 20-day EMA: | 94.29 | Buy |
| 50-day EMA: | 92.2 | Buy |
| 200-day EMA: | 59.82 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.85 | Buy |
| 20-day SMA: | 30.4 | Buy |
| 50-day SMA: | 22.87 | Buy |
| 200-day SMA: | 13.87 | Buy |
| 8-day EMA: | 35.03 | Buy |
| 20-day EMA: | 31.05 | Buy |
| 50-day EMA: | 24.98 | Buy |
| 200-day EMA: | 18 | Buy |
iShares Morningstar US Equity ETF Earnings Growth & ILCB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
iShares Morningstar US Equity ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||